| 000 | 01616 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516190048.0 | ||
| 264 | 0 | _c20140813 | |
| 008 | 201408s 0 0 eng d | ||
| 022 | _a1468-330X | ||
| 024 | 7 |
_a10.1136/jnnp-2013-307042 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAzzopardi, Laura | |
| 245 | 0 | 0 |
_aPredicting autoimmunity after alemtuzumab treatment of multiple sclerosis. _h[electronic resource] |
| 260 |
_bJournal of neurology, neurosurgery, and psychiatry _cJul 2014 |
||
| 300 |
_a795-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlemtuzumab |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xadverse effects |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xblood |
| 650 | 0 | 4 |
_aAutoimmunity _xdrug effects |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukins _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aYoung Adult |
| 650 | 0 | 4 | _aInterleukin-21 |
| 700 | 1 | _aThompson, Sara A J | |
| 700 | 1 | _aHarding, Katherine E | |
| 700 | 1 | _aCossburn, Mark | |
| 700 | 1 | _aRobertson, Neil | |
| 700 | 1 | _aCompston, Alastair | |
| 700 | 1 | _aColes, Alasdair J | |
| 700 | 1 | _aJones, Joanne L | |
| 773 | 0 |
_tJournal of neurology, neurosurgery, and psychiatry _gvol. 85 _gno. 7 _gp. 795-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/jnnp-2013-307042 _zAvailable from publisher's website |
| 999 |
_c23396253 _d23396253 |
||